Journal article

RE: ASK1, a new target in treating cardiorenal syndrome (CRS)

F Savira, AR Kompa, AJ Edgley, BM Jucker, RN Willette, DJ Kelly, BH Wang

International Journal of Cardiology | ELSEVIER IRELAND LTD | Published : 2020

DOI: 10.1016/j.ijcard.2020.05.050

Related Projects (2)

Project icon

NOVEL APPROACHES TO THE PREVENTION AND TREATMENT OF CHRONIC HEART DISEASE AND ITS CO-MORBID COMPLICATIONS

Cardiovascular disease (CVD) and its associated additional disorders constitute major public health problems, especially given the rapidly a..

Project icon

MECHANISMS UNDERLYING THE CONTRIBUTION OF UREMIC TOXINS TO CARDIORENAL SYNDROME

Cardiorenal syndrome (CRS) is an umbrella term that defines disorders of the heart and kidneys whereby “acute or chronic dysfunction in one ..

Grants

Funding Acknowledgements

This research was supported by National Health and Medical Research Council of Australia (Program Grants 1092642, BHW and DJK and Project Grant 1087355, BHWand ARK). FS is supported by Monash International Postgraduate Research Scholarship andMonash Graduate Scholarship.

Keywords

Cardiovascular System & Cardiology
Science & Technology
Ask1 Inhibitor
Life Sciences & Biomedicine
Apoptosis Signal-Regulating Kinase 1
3201 Cardiovascular Medicine and Haematology
Cardiac & Cardiovascular Systems
Cardiorenal Syndrome
32 Biomedical and Clinical Sciences